Cargando…
GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions
Multiple GLP-1-derived therapeutics are clinically used to treat type 2 diabetes and obesity. However, the underlying mechanism of how these drugs regulate the body weight of obese patients remains incompletely understood. Here, we report that the lipolysis effects of GLP-1 on β cells can depend on...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636013/ https://www.ncbi.nlm.nih.gov/pubmed/34869379 http://dx.doi.org/10.3389/fcell.2021.777026 |